Published in Mol Cell Biol on June 01, 1987
The yeast SNF3 gene encodes a glucose transporter homologous to the mammalian protein. Proc Natl Acad Sci U S A (1988) 2.99
Requirements for clinical PET: comparisons within Europe. Eur J Nucl Med Mol Imaging (2004) 2.75
Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways. Mol Biol Cell (1999) 1.35
78-kilodalton glucose-regulated protein is induced in Rous sarcoma virus-transformed cells independently of glucose deprivation. Mol Cell Biol (1988) 1.09
Transformation by the src oncogene alters glucose transport into rat and chicken cells by different mechanisms. Mol Cell Biol (1988) 1.03
Regulation of glucose transporter-specific mRNA levels in rat adipose cells with fasting and refeeding. Implications for in vivo control of glucose transporter number. J Clin Invest (1989) 0.99
The src oncogene can regulate a human glucose transporter expressed in chicken embryo fibroblasts. Mol Cell Biol (1990) 0.86
Tumour-specific activation of the sodium/iodide symporter gene under control of the glucose transporter gene 1 promoter (GTI-1.3). Eur J Nucl Med Mol Imaging (2003) 0.83
Differential regulation of glucose transporter isoforms by the src oncogene in chicken embryo fibroblasts. Mol Cell Biol (1991) 0.82
Changes in glucose metabolism and gene expression after transfer of anti-angiogenic genes in rat hepatoma. Eur J Nucl Med Mol Imaging (2007) 0.78
Transformation of Rat-1 fibroblasts with the v-src oncogene induces inositol 1,4,5-trisphosphate 3-kinase expression. Biochem J (1996) 0.78
Characterization of the avian GLUT1 glucose transporter: differential regulation of GLUT1 and GLUT3 in chicken embryo fibroblasts. Mol Biol Cell (1995) 0.77
Differential control of the functional cell surface expression and content of hexose transporter GLUT-1 by glucose and glucose metabolism in murine fibroblasts. Biochem J (1993) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Sequence and structure of a human glucose transporter. Science (1985) 8.03
The effects of reciprocal changes in temperature on the transformed state of cells infected with a rous sarcoma virus mutant. Virology (1971) 7.83
The specific interaction of the Rous sarcoma virus transforming protein, pp60src, with two cellular proteins. Cell (1981) 4.61
Insulin-stimulated translocation of glucose transport systems in the isolated rat adipose cell. Time course, reversal, insulin concentration dependency, and relationship to glucose transport activity. J Biol Chem (1981) 3.28
Analysis of a functional change in membrane in the process of cell transformation by Rous sarcoma virus; alteration in the characteristics of sugar transport. Virology (1970) 2.94
Temperature-dependent alterations in sugar transport in cells infected by a temperature-sensitive mutant of Rous sarcoma virus. Proc Natl Acad Sci U S A (1971) 2.83
Hexose transport in normal and in Rous sarcoma virus-transformed cells. J Biol Chem (1973) 2.50
Transit of pp60v-src to the plasma membrane. Proc Natl Acad Sci U S A (1982) 2.29
The effect of phorbol diesters on chicken embryo fibroblasts. Cancer Res (1977) 2.14
Temperature-dependent transformation of cells infected with a mutant of Bryan Rous sarcoma virus. J Virol (1972) 2.01
The glucose transporter of mammalian cells. Annu Rev Physiol (1985) 1.96
Stimulation of glucose transport in cultures of density-inhibited chick embryo cells. Proc Natl Acad Sci U S A (1971) 1.91
Glucose deprivation and hexose transporter polypeptides of murine fibroblasts. J Biol Chem (1986) 1.81
Induction of sugar transport in chick embryo fibroblasts by hexose starvation. Evidence for transcriptional regulation of transport. J Biol Chem (1975) 1.72
A tumor promoter stimulates phosphorylation on tyrosine. Biochem Biophys Res Commun (1983) 1.62
Derepression and carrier turnover: evidence for two distinct mechanisms of hexose transport regulation in animal cells. J Cell Physiol (1976) 1.61
The p53 cellular tumor antigen: gene structure, expression and protein properties. Biochim Biophys Acta (1985) 1.50
Cytochalasin B. A natural photoaffinity ligand for labeling the human erythrocyte glucose transporter. J Biol Chem (1982) 1.44
Photoaffinity labeling of the human erythrocyte D-glucose transporter. J Biol Chem (1982) 1.43
Energy-dependent and protein synthesis-independent recycling of the insulin-sensitive glucose transport mechanism in fat cells. J Biol Chem (1981) 1.34
Reversible association of cytochalasin B with the human erythrocyte membrane. Inhibition of glucose transport and the stoichiometry of cytochalasin binding. Biochim Biophys Acta (1973) 1.33
Paradoxical effects of cycloheximide and cytochalasin B on hamster cell hexose uptake. Proc Natl Acad Sci U S A (1976) 1.31
Evidence that translocation of the glucose transport activity is the major mechanism of insulin action on glucose transport in fat cells. J Biol Chem (1982) 1.28
Membrane effects of tumor promoters: stimulation of sugar uptake in mammalian cell cultures. J Cell Physiol (1979) 1.25
Transport of sugars in chick-embryo fibroblasts. Evidence for a low-affinity system and a high-affinity system for glucose transport. Biochem J (1976) 1.23
Biosynthetic precursors and in vitro translation products of the glucose transporter of human hepatocarcinoma cells, human fibroblasts, and murine preadipocytes. J Biol Chem (1985) 1.22
Sugar transport in chick embryo fibroblasts. II. Alterations in transport following transformation by a temperature-sensitive mutant of the Rous sarcoma virus. J Biol Chem (1974) 1.20
Proteins antigenically related to the human erythrocyte glucose transporter in normal and Rous sarcoma virus-transformed chicken embryo fibroblasts. Proc Natl Acad Sci U S A (1982) 1.20
Monoclonal antibodies to the glucose transporter from human erythrocytes. Identification of the transporter as a Mr = 55,000 protein. J Biol Chem (1985) 1.19
Stimulation of sugar uptake in cultured fibroblasts by epidermal growth factor (EGF) and EGF-binding arginine esterase. J Cell Physiol (1976) 1.19
Regulation of hexose carriers in chicken embryo fibroblasts. Effect of glucose starvation and role of protein synthesis. J Biol Chem (1983) 1.16
Photoaffinity labeling of the human erythrocyte nucleoside transporter by N6-(p-Azidobenzyl)adenosine and nitrobenzylthioinosine. Evidence that the transporter is a band 4.5 polypeptide. J Biol Chem (1983) 1.15
A major cytoplasmic glucose-regulated protein is associated with the Rous sarcoma virus pp60src protein. J Biol Chem (1982) 1.14
Glucose-specific cytochalasin B binding is increased in chicken embryo fibroblasts transformed by Rous sarcoma virus. J Biol Chem (1979) 1.10
The continuous growth of vertebrate cells in the absence of sugar. J Biol Chem (1981) 1.08
Phosphorylation of the glucose transporter in vitro and in vivo by protein kinase C. Nature (1985) 1.07
Identification of the erythrocyte nucleoside transporter as a band 4.5 polypeptide. Photoaffinity labeling studies using nitrobenzylthioinosine. J Biol Chem (1983) 1.04
Sugar transport in chick embryo fibroblasts. 3. Evidence for post-transcriptional and post-translational regulation of transport following serum addition. J Biol Chem (1974) 1.00
Regulation of sugar transport in chick embryo fibroblasts and in fibroblasts transformed by a temperature-sensitive mutant of the Rous sarcoma virus. J Cell Physiol (1976) 0.97
Hexose and amino acid transport by chicken embryo fibroblasts infected with temperature-sensitive mutant of Rous sarcoma virus. Comparison of transport properties of whole cells and membrane vesicles. Biochim Biophys Acta (1980) 0.96
Protein phosphorylation in a tetradecanoyl phorbol acetate-nonproliferative variant of 3T3 cells. Mol Cell Biol (1985) 0.94
Photolabeling of glucose-sensitive cytochalasin B binding proteins in erythrocyte, fibroblast and adipocyte membranes. Biochem Biophys Res Commun (1982) 0.94
Are lysosomes involved in hexose transport regulation? Turnover of hexose carriers and the activity of thiol cathepsins are arrested by cyanate and ammonia. Proc Natl Acad Sci U S A (1981) 0.93
Hexose transport in undifferentiated and differentiated BALB/c 3T3 preadipose cells: effects 12-O-tetradecanoylphorbol-13-acetate and insulin. J Cell Physiol (1982) 0.93
Reconstitution of glucose transport using human erythrocyte band 3. Biochim Biophys Acta (1983) 0.87
Kinetic parameters of hexose transport in hybrids between malignant and nonmalignant cells. J Cell Sci (1983) 0.83
Transport of potassium, amino acids, and glucose in cells transformed by Rous sarcoma virus. Fed Proc (1984) 0.82
Tumor promoter-stimulated translocation of glucose transport system in mouse embryo fibroblast Swiss 3T3 cell. Biochem Biophys Res Commun (1985) 0.80
Increased glucose uptake capacity of Rous-transformed cells and the relevance of deprivation derepression. Cancer Res (1981) 0.78
Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J (1991) 6.91
Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase. Science (1993) 6.07
Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol (1999) 5.93
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (1994) 5.19
Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol (1997) 4.70
Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3',5'-monophosphate. Science (1993) 4.61
MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science (1998) 4.45
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res (1999) 4.23
Diagnosis and management of closed internal degloving injuries associated with pelvic and acetabular fractures: the Morel-Lavallée lesion. J Trauma (1997) 4.13
Evidence that pp42, a major tyrosine kinase target protein, is a mitogen-activated serine/threonine protein kinase. Proc Natl Acad Sci U S A (1989) 3.98
Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol Cell Biol (1993) 3.13
Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. Science (1995) 3.10
Genetics of src: structure and functional organization of a protein tyrosine kinase. Curr Top Microbiol Immunol (1989) 3.03
Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res (1999) 2.88
Activation of the oncogenic potential of the avian cellular src protein by specific structural alteration of the carboxy terminus. EMBO J (1987) 2.67
Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res (1996) 2.58
Hexose transport in normal and in Rous sarcoma virus-transformed cells. J Biol Chem (1973) 2.50
Identification by mass spectrometry of threonine 97 in bovine myelin basic protein as a specific phosphorylation site for mitogen-activated protein kinase. J Biol Chem (1990) 2.40
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors. Cancer Res (2000) 2.39
Active MAP kinase in mitosis: localization at kinetochores and association with the motor protein CENP-E. J Cell Biol (1998) 2.37
Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner. J Cell Biol (1999) 2.35
Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras. Neuron (1994) 2.34
Autophosphorylation in vitro of recombinant 42-kilodalton mitogen-activated protein kinase on tyrosine. Proc Natl Acad Sci U S A (1991) 2.28
The inhibition by chloramphenicol of nascent protein formation in E. coli. Proc Natl Acad Sci U S A (1966) 2.12
Comparative inactivation of viruses by chlorine. Appl Environ Microbiol (1980) 2.04
Uridine transport and RNA synthesis in growing and in density-inhibited animal cells. J Cell Physiol (1971) 1.97
Tyrosine phosphorylation of specific proteins after mitogen stimulation of chicken embryo fibroblasts. Mol Cell Biol (1983) 1.92
The serine/threonine protein kinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation. Cancer Res (2005) 1.89
Sequence of pp42/MAP kinase, a serine/threonine kinase regulated by tyrosine phosphorylation. Nucleic Acids Res (1991) 1.89
An incomplete program of cellular tyrosine phosphorylations induced by kinase-defective epidermal growth factor receptors. J Biol Chem (1995) 1.86
A proline-rich sequence unique to MEK1 and MEK2 is required for raf binding and regulates MEK function. Mol Cell Biol (1995) 1.82
RAS and RAF-1 form a signalling complex with MEK-1 but not MEK-2. Mol Cell Biol (1994) 1.79
Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases. J Med Chem (1999) 1.70
Identification of phosphotyrosine-containing proteins in untransformed and Rous sarcoma virus-transformed chicken embryo fibroblasts. Mol Cell Biol (1982) 1.64
A tumor promoter stimulates phosphorylation on tyrosine. Biochem Biophys Res Commun (1983) 1.62
Efficacy of various forms of fixation of transverse fractures of the patella. J Bone Joint Surg Am (1980) 1.61
Reversal of Raf-1 activation by purified and membrane-associated protein phosphatases. Science (1995) 1.61
Phosphate transport, nucleotide pools, and ribonucleic acid synthesis in growing and in density-inhibited 3T3 cells. J Biol Chem (1971) 1.59
Biological properties of "partial" transformation mutants of Rous sarcoma virus and characterization of their pp60src kinase. J Virol (1981) 1.58
A monoclonal antibody against the c-erbB-2 protein enhances the cytotoxicity of cis-diamminedichloroplatinum against human breast and ovarian tumor cell lines. Cancer Res (1991) 1.58
Flk-1 as a target for tumor growth inhibition. Cancer Res (1996) 1.56
Biochemical characterization of a family of serine/threonine protein kinases regulated by tyrosine and serine/threonine phosphorylations. J Biol Chem (1991) 1.56
Phosphotyrosine-containing proteins and expression of transformation parameters in cells infected with partial transformation mutants of Rous sarcoma virus. J Virol (1983) 1.56
Ras-induced activation of Raf-1 is dependent on tyrosine phosphorylation. Mol Cell Biol (1996) 1.55
Growth factor-induced activation of a kinase activity which causes regulatory phosphorylation of p42/microtubule-associated protein kinase. Mol Cell Biol (1992) 1.53
The phorbol ester-dependent activator of the mitogen-activated protein kinase p42mapk is a kinase with specificity for the threonine and tyrosine regulatory sites. Proc Natl Acad Sci U S A (1992) 1.53
Dissociation of transformation parameters using temperature-conditional mutants of Rous sarcoma virus. Cell (1979) 1.52
Identification and characterization of a new mammalian mitogen-activated protein kinase kinase, MKK2. Mol Cell Biol (1993) 1.48
Inhibition of v-src-induced transformation by a GTPase-activating protein. Mol Cell Biol (1991) 1.46
Dual phosphorylation and autophosphorylation in mitogen-activated protein (MAP) kinase activation. Biochem J (1993) 1.45
Defective regulation of mitogen-activated protein kinase activity in a 3T3 cell variant mitogenically nonresponsive to tetradecanoyl phorbol acetate. Mol Cell Biol (1991) 1.43
Biochemical analysis of MEK activation in NIH3T3 fibroblasts. Identification of B-Raf and other activators. J Biol Chem (1995) 1.39
[Acne, hyperandrogenism and oral isotretinoin resistance. 23 cases. Therapeutic implications]. Ann Dermatol Venereol (1997) 1.39
A2B adenosine and P2Y2 receptors stimulate mitogen-activated protein kinase in human embryonic kidney-293 cells. cross-talk between cyclic AMP and protein kinase c pathways. J Biol Chem (1999) 1.38
Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site. J Biol Chem (1997) 1.38
Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals. J Biol Chem (1999) 1.38
Ribosomal RNA turnover in contact inhibited cells. Nat New Biol (1972) 1.37
The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function. Clin Cancer Res (2000) 1.33
Regulation of tetradecanoyl phorbol acetate-induced responses in NIH 3T3 cells by GAP, the GTPase-activating protein associated with p21c-ras. Mol Cell Biol (1992) 1.32
Reactivation of JC virus and development of PML in patients with multiple sclerosis. Neurology (2007) 1.32
Reversible G(1) arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(KIP1) independent of MAPK activity. J Biol Chem (2000) 1.26
p42/mitogen-activated protein kinase as a converging target for different growth factor signaling pathways: use of pertussis toxin as a discrimination factor. Cell Regul (1991) 1.24
Decreased adherence to the substrate in Rous sarcoma virus-transformed chicken embryo fibroblasts. Cell (1977) 1.24
Viability and apoptosis of human chondrocytes in osteochondral fragments following joint trauma. J Bone Joint Surg Br (2007) 1.21
Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent. Anticancer Drug Des (2000) 1.21
In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms. Am J Pathol (1998) 1.21
Medium-term results of the Bernese periacetabular osteotomy in the treatment of symptomatic developmental dysplasia of the hip. J Bone Joint Surg Br (2007) 1.20
Molecular analysis of the interactions between protein kinase C-epsilon and filamentous actin. J Biol Chem (1998) 1.20
Mitogen-stimulated tyrosine phosphorylation of a 42-kD cellular protein: evidence for a protein kinase-C requirement. J Cell Physiol (1988) 1.20
Proteins antigenically related to the human erythrocyte glucose transporter in normal and Rous sarcoma virus-transformed chicken embryo fibroblasts. Proc Natl Acad Sci U S A (1982) 1.20
Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I. Mol Cell Biol (1998) 1.18
Phosphorylation and activation of epidermal growth factor receptors in cells transformed by the src oncogene. Mol Cell Biol (1991) 1.18
Acute joint pathology and synovial inflammation is associated with increased intra-articular fracture severity in the mouse knee. Osteoarthritis Cartilage (2011) 1.18
Src phosphorylates the insulin-like growth factor type I receptor on the autophosphorylation sites. Requirement for transformation by src. J Biol Chem (1996) 1.18
Growth hormone and erythropoietin differentially activate DNA-binding proteins by tyrosine phosphorylation. Mol Cell Biol (1994) 1.16
New paradigms for the treatment of cancer: the role of anti-angiogenesis agents. Adv Cancer Res (2000) 1.15
Complete sequence of a cDNA encoding an active rat choline acetyltransferase: a tool to investigate the plasticity of cholinergic phenotype expression. J Neurosci Res (1989) 1.15
Fibroblasts transformed with v-src show enhanced formation of an inositol tetrakisphosphate. Science (1989) 1.14
Inhibition of glioma cell growth by a truncated platelet-derived growth factor-beta receptor. J Biol Chem (1994) 1.14
Phosphorylation of a 36,000 Mr cellular protein in cells infected with partial transformation mutants of rous sarcoma virus. Mol Cell Biol (1982) 1.14
Tethered swimming forces in the crawl, breast and back strokes and their relationship to competitive performance. J Biomech (1981) 1.14
Partial purification of a mitogen-activated protein kinase kinase activator from bovine brain. Identification as B-Raf or a B-Raf-associated activity. J Biol Chem (1994) 1.12
Direct tumor lysis by NK cells uses a Ras-independent mitogen-activated protein kinase signal pathway. J Immunol (2000) 1.10
Immune complex kinase assays for mitogen-activated protein kinase and MEK. Methods Enzymol (1995) 1.10
Glucose-specific cytochalasin B binding is increased in chicken embryo fibroblasts transformed by Rous sarcoma virus. J Biol Chem (1979) 1.10
Optimization of the resolution of phosphoamino acids by one-dimensional thin-layer electrophoresis. Biotechniques (1993) 1.10
Antiapoptotic signaling in LNCaP prostate cancer cells: a survival signaling pathway independent of phosphatidylinositol 3'-kinase and Akt/protein kinase B. Cancer Res (1999) 1.09
Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice. Proc Natl Acad Sci U S A (2000) 1.08
c phosphorylation and activation of the IGF-I receptor in src-transformed cells. J Biol Chem (1994) 1.07
Constitutive phosphorylation of the receptor for insulinlike growth factor I in cells transformed by the src oncogene. Mol Cell Biol (1990) 1.07
Antagonism by gram-negative bacteria to growth of Yersinia enterocolitica in mixed cultures. Appl Environ Microbiol (1984) 1.05
Hard-to-reach families in a comprehensive care program. JAMA (1967) 1.05
Mutations in the SH3 domain of the src oncogene which decrease association of phosphatidylinositol 3'-kinase activity with pp60v-src and alter cellular morphology. J Virol (1992) 1.05
Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies. Gynecol Oncol (2013) 1.04
p185c-erbB-2 signal enhances cisplatin-induced cytotoxicity in human breast carcinoma cells: association between an oncogenic receptor tyrosine kinase and drug-induced DNA repair. Cancer Res (1994) 1.04
Protease-activated "prodrugs" for cancer chemotherapy. Proc Natl Acad Sci U S A (1980) 1.04
Tumorigenicity of partial transformation mutants of Rous sarcoma virus. J Virol (1982) 1.04
The role of the acetabular labrum and the transverse acetabular ligament in load transmission in the hip. J Bone Joint Surg Am (1998) 1.04